메뉴 건너뛰기




Volumn 17, Issue 6, 2000, Pages 389-391

Nebulized hydromorphone for dyspnea in hospice care of advanced cancer

Author keywords

cancer; dyspnea; hospice; nebulized hydromorphone

Indexed keywords

HYDROMORPHONE; NARCOTIC ANALGESIC AGENT;

EID: 0034334331     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910001700609     Document Type: Article
Times cited : (19)

References (23)
  • 1
    • 0031919265 scopus 로고    scopus 로고
    • Dyspnea in patients with advanced cancer: incidence, causes and treatments
    • Ripamonti C, Fulfaro F, Bruera E: Dyspnea in patients with advanced cancer: incidence, causes and treatments. Cancer Treat Rev. 1998; 24: 69-80.
    • (1998) Cancer Treat Rev , vol.24 , pp. 69-80
    • Ripamonti, C.1    Fulfaro, F.2    Bruera, E.3
  • 2
    • 0033036615 scopus 로고    scopus 로고
    • Palliative management of dyspnea in advanced cancer
    • LeGrand SB, Walsh D: Palliative management of dyspnea in advanced cancer. Curr Opin Oncol. 1999; 11: 250-254.
    • (1999) Curr Opin Oncol , vol.11 , pp. 250-254
    • LeGrand, S.B.1    Walsh, D.2
  • 3
    • 0026048395 scopus 로고
    • Management of dyspnea in advanced cancer
    • Nelson K, Walsh D: Management of dyspnea in advanced cancer. Cancer Bull. 1991; 4: 423-426.
    • (1991) Cancer Bull , vol.4 , pp. 423-426
    • Nelson, K.1    Walsh, D.2
  • 4
    • 0028431533 scopus 로고
    • Clinical application of nebulized opioids for treatment of dyspnea in patients with malignant disease
    • Farncombe M, Chater S: Clinical application of nebulized opioids for treatment of dyspnea in patients with malignant disease. Support Care Cancer. 1994; 2: 184-187.
    • (1994) Support Care Cancer , vol.2 , pp. 184-187
    • Farncombe, M.1    Chater, S.2
  • 5
    • 0027304359 scopus 로고
    • Dyspnea in advanced cancer
    • Walsh D: Dyspnea in advanced cancer. Lancet. 1993; 342: 450-451.
    • (1993) Lancet , vol.342 , pp. 450-451
    • Walsh, D.1
  • 6
    • 0027207554 scopus 로고
    • Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease
    • Farncombe M, Chater S: Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease. J Pain Symptom Manage. 1993; 8: 221-225.
    • (1993) J Pain Symptom Manage , vol.8 , pp. 221-225
    • Farncombe, M.1    Chater, S.2
  • 7
    • 0030043784 scopus 로고    scopus 로고
    • Management of dyspnea and cough in patients with cancer
    • Dudgeon D, Rosenthal S: Management of dyspnea and cough in patients with cancer. Hematol Oncol Cli North Am. 1996; 10: 157-171.
    • (1996) Hematol Oncol Cli North Am , vol.10 , pp. 157-171
    • Dudgeon, D.1    Rosenthal, S.2
  • 8
    • 0031230043 scopus 로고    scopus 로고
    • Nebulized opioids in the treatment of dyspnea
    • Quelch PC, Faulkner DE, Yun JW: Nebulized opioids in the treatment of dyspnea. J Palliative Care. 1997; 13(3): 48-52.
    • (1997) J Palliative Care , vol.13 , Issue.3 , pp. 48-52
    • Quelch, P.C.1    Faulkner, D.E.2    Yun, J.W.3
  • 9
    • 0027949007 scopus 로고
    • The use of nebulized opioids for breathlessness: a chart review
    • Farncombe M, Chater S, Gillin A: The use of nebulized opioids for breathlessness: a chart review. Palliat Med. 1994; 8: 306-312.
    • (1994) Palliat Med , vol.8 , pp. 306-312
    • Farncombe, M.1    Chater, S.2    Gillin, A.3
  • 11
    • 0026058241 scopus 로고
    • Continuous intravenous infusion of morphine for severe dyspnea
    • Cohen MH, Johnston Anderson A, Krasnow SH, et al.: Continuous intravenous infusion of morphine for severe dyspnea. Southern Med J. 1991; 84: 229-234.
    • (1991) Southern Med J , vol.84 , pp. 229-234
    • Cohen, M.H.1    Johnston Anderson, A.2    Krasnow, S.H.3
  • 12
    • 0030875341 scopus 로고    scopus 로고
    • Oral morphine as symptomatic treatment of dyspnea in patients with advanced cancer
    • Boyd K, Kelly M: Oral morphine as symptomatic treatment of dyspnea in patients with advanced cancer. Palliat Med. 1997; 11: 277-281.
    • (1997) Palliat Med , vol.11 , pp. 277-281
    • Boyd, K.1    Kelly, M.2
  • 13
    • 0019766724 scopus 로고
    • Effects of dihydrocodeine, alcohol and caffeine on obstructive lung disease and normal blood gases
    • Woodcock AA, Gross ER, Gellert A, Shah S, Johnson M, Geddes D: Effects of dihydrocodeine, alcohol and caffeine on obstructive lung disease and normal blood gases. N Engl J Med. 1981; 305: 1611-1616.
    • (1981) N Engl J Med , vol.305 , pp. 1611-1616
    • Woodcock, A.A.1    Gross, E.R.2    Gellert, A.3    Shah, S.4    Johnson, M.5    Geddes, D.6
  • 14
    • 0008393215 scopus 로고
    • Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients?
    • Conno F de, Spoldi E, Caraceni A, Ventafridda V: Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients? Palliat Med. 1991; 5: 237-243.
    • (1991) Palliat Med , vol.5 , pp. 237-243
    • Conno F, d.e.1    Spoldi, E.2    Caraceni, A.3    Ventafridda, V.4
  • 15
    • 0025134262 scopus 로고
    • Long-term management of respiratory symptoms in advanced cancer
    • Cowcher K, Hanks G: Long-term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage. 1990; 5: 320-330.
    • (1990) J Pain Symptom Manage , vol.5 , pp. 320-330
    • Cowcher, K.1    Hanks, G.2
  • 16
    • 0024498919 scopus 로고
    • Opioids inhibition of neurally medicated mucous secretion in human bronchi
    • Roger DF, Barnes PG: Opioids inhibition of neurally medicated mucous secretion in human bronchi. Lancet. 1989; I: 930-931.
    • (1989) Lancet , vol.I , pp. 930-931
    • Roger, D.F.1    Barnes, P.G.2
  • 17
    • 0023149809 scopus 로고
    • Neuropeptides in the lung: Localization, function, and pathophysiologic implications
    • Barnes P: Neuropeptides in the lung: Localization, function, and pathophysiologic implications. J. Aller Clini Immuno. 1987; 79(2): 285-295.
    • (1987) J. Aller Clini Immuno , vol.79 , Issue.2 , pp. 285-295
    • Barnes, P.1
  • 18
    • 0002295470 scopus 로고    scopus 로고
    • Single-dose randomized controlled trial of nebulized morphine in patients with cancer-related breathlessness
    • Davis CL, Penn K, A”Hern R, et al.: Single-dose randomized controlled trial of nebulized morphine in patients with cancer-related breathlessness. Palliat Med. 1996; 10: 64-65.
    • (1996) Palliat Med , vol.10 , pp. 64-65
    • Davis, C.L.1    Penn, K.2    A”Hern, R.3
  • 19
    • 0029072672 scopus 로고
    • Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease
    • Masood AR, Reed JW, Thomas SHL: Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax. 1995; 50: 629-634.
    • (1995) Thorax , vol.50 , pp. 629-634
    • Masood, A.R.1    Reed, J.W.2    Thomas, S.H.L.3
  • 20
    • 0030917803 scopus 로고    scopus 로고
    • Disabling dyspnea in patients with advanced disease: lack of effect of nebulized morphine
    • Noseda A, Carpiaux JP, Markstein C, et al.: Disabling dyspnea in patients with advanced disease: lack of effect of nebulized morphine. Eur Respir J. 1997; 10: 1079-1083.
    • (1997) Eur Respir J , vol.10 , pp. 1079-1083
    • Noseda, A.1    Carpiaux, J.P.2    Markstein, C.3
  • 21
    • 0030860177 scopus 로고    scopus 로고
    • Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study
    • Lawlor P, Turner K, Hanson J, Bruera E: Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain. 1997; 72: 79-85.
    • (1997) Pain , vol.72 , pp. 79-85
    • Lawlor, P.1    Turner, K.2    Hanson, J.3    Bruera, E.4
  • 23
    • 0003687687 scopus 로고    scopus 로고
    • Symptom management algorithms
    • Yakima, WA: Intellicard
    • Seaman L: Symptom management algorithms. A handbook for palliative care. Yakima, WA: Intellicard, 1999, 50-51.
    • (1999) A handbook for palliative care , pp. 50-51
    • Seaman, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.